With DoorDash projecting over $10 billion in 2025 revenue, CBD Life Sciences Inc. is set to tap into one of the fastest-growing delivery markets in the country, potentially unlocking a multi-million dollar revenue stream and driving a projected 30-40% increase in annual revenue for CBDL. SCOTTSDALE, ARIZONA / ACCESSWIRE / January 14, 2025 / CBD Life Sciences Inc. (OTC Pink:CBDL), a leading innovator in the CBD industry, proudly announces that it is in the final stages of securing approval to sell its premium CBD products on DoorDash, one of the most prominent on-demand delivery platforms in the United States.
Walmart Marketplace saw a 60% year-over-year growth in gross merchandise volume, with third-party sellers accounting for over 50% of online sales, contributing to Walmart's e-commerce revenue surpassing $100 billion in 2024. This makes it a powerful platform for rapid brand growth and a game-changing opportunity for CBDL's breakthrough product line.
Demonstrating shareholder confidence, CBDL commits to repurchasing 10% of revenue quarterly. SCOTTSDALE, AZ / ACCESSWIRE / December 18, 2024 / CBD Life Sciences Inc. (OTC Pink:CBDL), a leading innovator in the CBD and wellness industry, is thrilled to announce a significant milestone in its ongoing commitment to delivering shareholder value.
| Specialty Retail Industry | Consumer Discretionary Sector | Lisa Anne Nelson CEO | OTC PINK Exchange | 12482V103 CUSIP |
| US Country | 3 Employees | - Last Dividend | 22 Apr 2024 Last Split | - IPO Date |
CBD Life Sciences Inc. is a company that focuses on the development and marketing of cannabidiol (CBD) based organic products. With its operations based in Scottsdale, Arizona, the company taps into the growing demand for CBD products by offering a diverse range of options catering to various needs and preferences. The emphasis on organic composition underlines its commitment to providing natural solutions for health and wellness.